ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion

Beck V, Herold H, Benge A, Luber B, Hutzler P, Tschesche H, Kessler H, Schmitt M, Geppert HG, Reuning U (2005)
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 37(3): 590-603.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ;
Abstract / Bemerkung
We have recently described that integrin alphavbeta3 upon interaction with its major extracellular matrix ligand vitronectin induces adhesion, motility, and proliferation of human ovarian cancer cells. Due to the important function of alphavbeta3 in cancer cell biology, it has been the effort of many scientific approaches to specifically target alphavbeta3-mediated cell adhesion and tumorbiological effects arising thereof by synthetic integrin antagonists. More recently, proteins of the ADAM family have been recognized as naturally occurring integrin ligands. Among those, human ADAM 15 which encompasses the integrin binding RGD motif was shown to interact with integrin alphavbeta3. Thus, we investigated in human ovarian OV-MZ-6 cancer cells, expressing both ADAM 15 and alphavbeta3, whether ADAM15 might affect alphavbeta3-mediated tumorbiological effects. We stably (over)expressed ADAM15 or its extracellular domain in OV-MZ-6 cells as well as respective ADAM15 mutants containing the tripeptide SGA instead of RGD. Cells (over)expressing ADAM 15-RGD exhibited a significantly reduced alphavbeta3-mediated adhesion to vitronectin. Also, a significant time-dependent decline in numbers of cells cultivated on vitronectin was noticed. This effect was found to be rather due to impaired xvp3-mediated cell adhesion than decreased cell proliferation rates, since de novo DNA synthesis was not significantly altered by elevated ADAM 15 expression. Moreover, a substantially decreased random cellular motility was noticed as a function of ADAM 15 encompassing an intact RGD motif. In conclusion, our results point to a physiological role of ADAM 15 as a natural binding partner of integrin alphavbeta3 thereby loosening tumor cell adhesion to the underlying matrix and regulating tumor cell migration and invasion. (C) 2004 Elsevier Ltd. All rights reserved.
Erscheinungsjahr
Zeitschriftentitel
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Band
37
Zeitschriftennummer
3
Seite
590-603
ISSN
PUB-ID

Zitieren

Beck V, Herold H, Benge A, et al. ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2005;37(3):590-603.
Beck, V., Herold, H., Benge, A., Luber, B., Hutzler, P., Tschesche, H., Kessler, H., et al. (2005). ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 37(3), 590-603. doi:10.1016/j.biocel.2004.08.005
Beck, V., Herold, H., Benge, A., Luber, B., Hutzler, P., Tschesche, H., Kessler, H., Schmitt, M., Geppert, H. G., and Reuning, U. (2005). ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 37, 590-603.
Beck, V., et al., 2005. ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 37(3), p 590-603.
V. Beck, et al., “ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion”, INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, vol. 37, 2005, pp. 590-603.
Beck, V., Herold, H., Benge, A., Luber, B., Hutzler, P., Tschesche, H., Kessler, H., Schmitt, M., Geppert, H.G., Reuning, U.: ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 37, 590-603 (2005).
Beck, V, Herold, H, Benge, A, Luber, B, Hutzler, P, Tschesche, Harald, Kessler, H, Schmitt, M, Geppert, HG, and Reuning, U. “ADAM15 decreases integrin alpha v beta 3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion”. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 37.3 (2005): 590-603.

30 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

ADAMs in cancer cell proliferation and progression.
Mochizuki S, Okada Y., Cancer Sci 98(5), 2007
PMID: 17355265
ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease.
Kuefer R, Day KC, Kleer CG, Sabel MS, Hofer MD, Varambally S, Zorn CS, Chinnaiyan AM, Rubin MA, Day ML., Neoplasia 8(4), 2006
PMID: 16756724

52 References

Daten bereitgestellt von Europe PubMed Central.

Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction.
Hapke S, Kessler H, Luber B, Benge A, Hutzler P, Hofler H, Schmitt M, Reuning U., Biol. Chem. 384(7), 2003
PMID: 12956424
A family of cellular proteins related to snake venom disintegrins.
Weskamp G, Blobel CP., Proc. Natl. Acad. Sci. U.S.A. 91(7), 1994
PMID: 8146185

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 15618016
PubMed | Europe PMC

Suchen in

Google Scholar